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Abstract
Background: Rolling circle amplification of ligated probes is a simple and sensitive means for
genotyping directly from genomic DNA. SNPs and mutations are interrogated with open circle
probes (OCP) that can be circularized by DNA ligase when the probe matches the genotype. An
amplified detection signal is generated by exponential rolling circle amplification (ERCA) of the
circularized probe. The low cost and scalability of ligation/ERCA genotyping makes it ideally suited
for automated, high throughput methods.
Results: A retrospective study using human genomic DNA samples of known genotype was
performed for four different clinically relevant mutations: Factor V Leiden, Factor II prothrombin,
and two hemochromatosis mutations, C282Y and H63D. Greater than 99% accuracy was obtained
genotyping genomic DNA samples from hundreds of different individuals. The combined process
of ligation/ERCA was performed in a single tube and produced fluorescent signal directly from
genomic DNA in less than an hour. In each assay, the probes for both normal and mutant alleles
were combined in a single reaction. Multiple ERCA primers combined with a quenched-peptide
nucleic acid (Q-PNA) fluorescent detection system greatly accellerated the appearance of signal.
Probes designed with hairpin structures reduced misamplification. Genotyping accuracy was
identical from either purified genomic DNA or genomic DNA generated using whole genome
amplification (WGA). Fluorescent signal output was measured in real time and as an end point.
Conclusions: Combining the optimal elements for ligation/ERCA genotyping has resulted in a
highly accurate single tube assay for genotyping directly from genomic DNA samples. Accuracy
exceeded 99 % for four probe sets targeting clinically relevant mutations. No genotypes were called
incorrectly using either genomic DNA or whole genome amplified sample.
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Background
Sequencing of the human genome has led to the identifi-
cation of mutations and single nucleotide polymor-
phisms (SNPs) that can be linked with specific
phenotypes. A number of assays have been developed to
genotype known SNPs and mutations. However, the
majority of these methods have many steps and are diffi-
cult to automate. Currently, most genotyping methods
require that the target region of the genomic DNA be
amplified using PCR prior to the genotyping assay
(reviewed in [1,2]). Following amplification, the PCR
product is either sequenced directly, or probed for the
mutation of interest. Similarly, OCP ligation/ERCA can be
used to accurately genotype PCR products in a biallelic
format, where the probes for both alleles are present in a
single reaction [3]. The OCP ligation/ERCA method is
based on ligation dependent circularization of allele spe-
cific DNA probes followed by exponential rolling circle
amplification of the circularized probes [4,5]. ERCA
probes have also been variously described as 'padlock
probes' [6,7] or 'circularizable probes' [4]. Although OCP
ligation/ERCA can be used to genotype PCR products, it
also provides a means for directly genotyping genomic
DNA without requiring an initial amplification of the
genomic DNA locus. For example, we recently described a
high throughput ligation/ERCA protocol for genotyping
genomic DNA samples in microtiter plates [8].
This report describes modifications to OCP ligation/ERCA
genotyping that reduce reaction time and improve accu-
racy to above 99%. Methods for improving accuracy
include simultaneous detection of two alleles per well,
probes designed to contain hairpin sequences that regu-
late ligation discrimination and prevent nonspecific
amplification, and introduction of a Q-PNA fluorescent
detection system[9]. Improvements in probe design, roll-
ing circle reaction design, and assay methods were inte-
grated into an improved high accuracy genotyping assay,
and the utility of the method was demonstrated for four
clinically important mutations. The Q-PNA fluorescent
detection system produced a six-fold reduction in time to
result.
In many instances only limited quantities of genomic
DNA are available from clinical samples for genetic test-
ing. DNA can also be limiting when large numbers of
assays must be performed on a single sample. Recently, a
whole genome amplification method (WGA) has been
developed that is capable of accurately producing large
quantities of genomic DNA from limited sample [10,11].
In cases where genomic DNA was limiting, WGA genomic
DNA was substituted for genomic DNA. Complete and
faithful amplification of the entire genome resulted in
WGA product that could be substituted for genomic DNA
without affecting the accuracy of genotyping. WGA DNA
amplification and OCP ligation/ERCA can be combined
to create an automated high throughput mutation assay
that includes DNA amplification from limiting samples
and allele detection in a single tube.
Results
Probe Design
The OCP ligation/ERCA assay was improved to meet the
requirements for fast, and accurate, genotyping. Probes
for both alleles were combined in a single reaction tube
(Figure 1). One OCP annealed perfectly to the normal
sequence of interest, and the other targeted the mutant.
The 3' terminal nucleotide of the OCP annealed opposite
the variant nucleotide. If the OCP and the target matched
at the mutation site, the OCP was circularized by ligase. If
the OCP was mismatched at the 3' end, it was not ligated.
There are a number of advantages to having both probes
present in the same reaction, as opposed to having each
probe in a separate reaction [3]. For instance, if amplifica-
tion fails in a biallelic (ie., two allele) reaction, signal is
not generated for either allele, and the result can be dis-
carded. However, if only one of the two reactions fail in a
two reaction/ single allele per well format, a heterozygote
could be miscalled as a homozygote. Furthermore, the
two allele per well format reduced non-specific amplifica-
tion. With both mutant and normal OCP in the reaction,
either one or the other or both OCPs were circularized,
depending on the genotype. Therefore, there was a specific
rolling circle reaction in every assay, regardless of the gen-
otype. The kinetics of the specific rolling circle reaction
were sufficiently rapid so that non-specific amplification
was greatly reduced or eliminated. Details of the mecha-
nism of the Exponential Rolling Circle Amplification
(ERCA) reaction are shown in Figure 2.
The exponential amplification of the ligated probe
sequence generates double stranded DNA products that
are unit lengths of the probe [4]. Electrophoretic separa-
tion on an agarose gel generates a ladder of DNA bands as
seen in Figure 3. Typically, the products ranged in size
from 80 bases to 1.2 kb, with most products less than 500
bases long. The ERCA products for normal and mutant
alleles incorporate a different fluorescent P1 primer. In
Figure 3, signal from the normal allele results in FAM
(false color green) fluorescence, while signal from the
mutant allele results in Cy3 (false color red) fluorescence.
A sample with heterozygous genotype produces both
colors.
The OCPs were redesigned to incorporate a hairpin struc-
ture (Figure 4) that improved target specificity analogous
to beacon [12] probe design. Parameters affecting the sta-
bility of the hairpin were tailored to increase the specifi-
city of target recognition. Target directed hybridization
using a hairpin is more specific than hybridization of aBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/21
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linear probe because the structure of the hairpin probe is
maintained in a folded state unless the hairpin sequence
encounters its preferred target sequence. If the probe does
not encounter the correct target, the hairpin will remain
self-annealed, reducing the possibility of nonspecific or
transient annealing events. Only the extensive base pair-
ing between the probe and target sequence is sufficient to
disrupt the hairpin.
The new probe design also provides a way to reduce back-
ground by rendering unused probe inert. (Figure 5). Dur-
ing ERCA, the 3'-end of the hairpin of unused probe is
extended by DNA polymerase to produce a non-reactive
double-stranded product (data not shown). In the
absence of a method such as this for either removing or
inactivating unused OCP, nonspecific background ampli-
fication can occur [13]. Sequencing of misamplification
products (data not shown, [14]) has revealed that misam-
plification products produced in the absence of ligase usu-
ally consist of a short OCP-derived sequence immediately
flanked by primer sequences. Each 'primer-OCP-primer'
unit was repeated dozens or hundreds of times in tandem.
The unit sequence varied randomly from reaction to reac-
tion, and sometimes more than one sequence was present
in a reaction. The exact mechanism for generating and
expanding misamplification products with this overall
sequence motif is not completely understood. However,
improved probe design that results in enzymatic elimina-
tion of unused OCPs, as demonstrated with the 3' hairpin
OCP, can reduce or eliminate unwanted nonspecific
amplifications.
To determine the effect of the 3' hairpin on genotyping
accuracy, probes with and without 3' hairpins were
designed for both the Factor V Leiden and Hemochroma-
tosis H63D mutations (Table 1). Control probes lacking
hairpins were constructed in two different ways: 1) Hair-
pins in the FVL probes were removed by simply deleting
the non-target directed OCP sequence involved in hairpin
formation. This did not change priming sites or the base
pairing between the probe and target, but non-hairpin
probes were reduced in length by 10 nucleotides com-
pared to the hairpin probes. 2) To eliminate the 3' hairpin
without changing the length of the OCP, the hairpins in
the H63D probes were removed by changing the sequence
of the OCP such that the length of the probes was con-
served but the base pairing in the hairpin was disrupted.
Real time ERCA genotyping reactions were performed
Figure 1
Ligation of OCP to genomic DNA target Open circle probe (OCP) anneals to genomic DNA target, and the 3' base either base 
pairs with the target (red) or creates a mismatch (blue). The matched OCP is circularized by ligase, and becomes topologically 
linked to the target.
Hybridization
And Ligation
Match:
Circular Probe
Mismatch:
Not Circularized
Genomic 
Target
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using FVL and H63D probes with and without 3' hairpins
(Figures 6, 7, 8 and 9). The fluorescence versus time was
plotted for each of 48 samples, grouped according to gen-
otype. The genotyping signals appeared in as little as 10
minutes using the Q-PNA detection system. Genotyping
calls were made as described in Methods, (Determination
of Genotypes, Real Time OCP ligation/ERCA). For both
FVL and H63D, nonspecific amplification occurred when
OCPs lacked the hairpin structure. Strong nonspecific sig-
nal appeared for samples known to be either homozygous
mutant or normal, frequently generating a heterozygous
genotyping miscall. 48 samples were genotyped for FVL
and H63. FVL genotyping with the non-hairpin probes
resulted in unacceptably high error, with only 65% of the
samples called correctly (Figure 6). Results for non-hair-
pin H63D probes were similar, with only 65% called cor-
Figure 2
ERCA using Q-PNA, P1 and P2 Exponential amplification of circularized OCP was performed using primers P1 and P2. P1 is a 
composite of a Q-PNA annealed to a fluorescent DNA primer specific for the circle sequence directed against one allele. Q-
PNA anneals to the fluorescent DNA primer such that the c-terminal quencher on the PNA quenches the 5' fluorescent moi-
ety (either FAM or Cy3) on the DNA primer. P2 is a DNA primer with the same strand orientation as the circle, complemen-
tary to the product of the primary rolling circle reaction. Amplification of the circle specific for only one of the two alleles is 
illustrated. ERCA begins when P1 anneals to the circle (1), and polymerase copies the circle sequence, eventually copying the 
entire circle. The polymerase begins displacing the previously synthesized product, opening up single stranded P2 binding sites 
(2). Each turn of displacement synthesis around the circle exposes another P2 binding site, and the resulting synthesis from the 
annealed P2 primers results in the displacement of downstream primers and products, including the PNA (3). Displacement of 
the PNA separates the fluorescent label on the DNA from the quencher on the PNA, producing fluorescent signal specific for 
the P1/circle pair (4). Displacement of the downstream primers and products also opens up additional P1 binding sites, and the 
process continues in an exponential cascade.
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rectly (Figure 8). In both cases, the non-hairpin
genotyping reactions showed a dramatic increase in the
incidence of late appearing, non-specific signal. When the
hairpin containing OCPs were used, all 96 samples were
genotyped correctly (Figures 7 and 9).
To increase the accuracy of genotyping, probes for both
alleles were combined in a single tube format. For hetero-
zygotes, the two probes are concurrently amplified in the
ERCA reaction. Exponential amplification of circularized
OCP requires primers P1 and P2 (see Figure 2). The con-
current amplification of mutant and normal probes is
Figure 3
Agarose gel analysis of ERCA reaction products. Assay conditions were as described in Methods for specific Factor V Leiden 
Mutation ligation/ERCA genotyping assay. Following ERCA, reaction products were separated on a 1.5% agarose gel in 1X TBE 
at 200 Volts for 2 hours. FAM and Cy3 fluorescence were visualized using a Molecular Dynamics FluorImager. FAM signal was 
produced during ERCA in response to the normal allele, and Cy3 signal in response to the mutant. Sample in lanes 1 and 2 con-
tained genomic DNA target homozygous for the Factor V Leiden mutation (M), lanes 3 and 4 were heterozygous for the muta-
tion (H), and lane 5 was homozygous normal (N). Three different exposures of the same gel, lanes 1–5, are shown. On the left, 
the Cy3 fluorescent product is shown in red. In the center, the FAM product is shown in green. On the right, both exposures 
are shown overlapped. Overlapping FAM and Cy3 produces a yellow signal in this exposure. Migration of 100, 500, and 1000 
base pair DNA size markers (not shown) is indicated by arrows at right.
Overlapping 
FAM and Cy3 Cy3  FAM
12345 12345 12345
MH N MH N MH N
100
500
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kept in balance by using the same P2 for each probe. P1
primers were routinely titrated to determine optimum
concentration [4]. This approach greatly reduces the diffi-
culty of balancing the kinetics of biallelic ERCA amplifica-
tions. If the P2 primer is common to both OCPs, only P1
priming efficiencies need to be similar, greatly simplifying
the process of obtaining balanced reaction kinetics in a
biallelic assay.
The use of several P1 and P2 primers, which initiate DNA
synthesis from multiple positions on the probe and prod-
uct, increases ERCA rate, sensitivity and specificity ([15],
data not shown). Therefore, secondary amplification
primers were designed for each probe. In genotyping reac-
tions where two probes were present in a single reaction,
the secondary primers were designed to anneal to target
specific sequences shared by both OCPs, in the 5' and/or
3' arms (Table 1).
Genotyping Accuracy
The improvements to the OCP ligation/ERCA genotyping
reaction outlined above were incorporated into four gen-
otyping assays, and a study was performed to test the reac-
tion design for genotyping accuracy. Probes for the Factor
V Leiden (FVL) mutant and normal alleles (see Table 1)
were designed using the parameters outlined in Methods.
These probes were used to screen a 216 patient sample set
that had been previously genotyped using RFLP. The sam-
ple groups were enriched for the mutant genotypes that
normally occur at very low frequency in the population.
For example, the FVL sample group contained 105 nor-
mal, 98 heterozygous, and 13 homozygous mutant
patient samples for the FVL allele. Of 352 genotyping reac-
tions performed in triplicate (1056 total FVL reactions),
only 6 samples gave inconsistent genotyping results and
had to be repeated. A repeat was indicated if any of the
three independent experiments did not agree. By perform-
ing reactions in triplicate, the assay yielded results that
were 100% accurate, with a 1.7% repeat rate. Reactions
performed only once had an accuracy of 99.4 %. Results
were visualized as both real time and end-point, and a
representative FVL genotyping experiment is shown in
Figure 10. The genotype for each sample was determined
Figure 4
Specific annealing of 3' hairpin OCP to its genomic target followed by ligation. The hairpin structure can increase OCP discrim-
ination during ligation by providing a two state equilibrium for the OCP, where OCP is either in the hairpin form or annealed 
to target. A mismatch between target and OCP favors the intra-molecular hairpin formation. A match between the OCP and 
the target provides an extended region of complementarity that is sufficient to maintain stable binding of the 3' end of the OCP 
to the target, allowing ligase to circularize the OCP. This balance contributes to accurate and sensitive allele discrimination.
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as outlined in Methods, and compared to the known
genotype. The number of samples genotyped and the
accuracy of genotyping are summarized in Table 2.
Probes for the Factor II prothrombin (FII) mutant and
normal alleles (see Table 1) were designed as discussed in
Methods. These probes were used to screen a 298 patient
sample set that was previously genotyped using RFLP.
There were two mutant genotypes, 12 heterozygotes, and
284 homozygous normal genotypes. Because mutant
patient samples were limiting, a separate sample group
that consisted of multiple repeats of the same Factor II
mutant and heterozygous samples was screened. As with
the genotyping assays described above, Factor II pro-
thrombin (FII) mutant genotyping results were also visu-
alized either in real time or as an end-point assay (Figure
11). Summary of results is shown in Table 2. Samples
probed for the Factor II mutation were genotyped with
99.5% accuracy within a single assay, 100% accuracy if
performed in triplicate.
Probes for the two Hemochromatosis mutations H63D
and C282Y were designed using the parameters outlined
in Methods and used to screen patient sample sets of
known genotype (probe sequences in Table 1). There were
138 samples screened for H63D and 190 samples
screened for C282Y. This sample group was also enriched
for the mutant genotype, containing 89 homozygous nor-
mal, 48 heterozygous and 1 homozygous mutant (the sin-
gle mutant was repeated 29 times) for the H63 allele and
84 normal, 93 heterozygous and 13 homozygous mutant
patient samples for the C282 allele. Examples of typical
genotyping results for H63D are shown in Figure 12 and
results for C282Y are shown in Figure 13. Genotyping
results were visualized as both real time reaction traces
and as an end-point assay. Samples screened for both
hemochromatosis mutations were genotyped with 99.5%
accuracy within a single assay, 100% accuracy if per-
formed in triplicate (Table 2).
Discussion
OCP ligation/ERCA can be used to directly probe genomic
DNA for SNPs or mutations, and the entire process can be
Figure 5
3' Hairpin OCPs design allows conversion of unused OCPs to inert double-stranded form. If the OCP is not circularized, the 
single stranded region of the unligated linear probe can bind P1 primer and be copied, a process that can lead to misamplifica-
tion of unligated probe. To reduce the potential for misamplification, a 3' hairpin has been designed into the OCP. During 
ERCA reaction, 3' hairpin is extended by polymerase, resulting in an extended hairpin with minimal single strandedness, which 
is less likely to participate in faulty priming reactions that result in misamplification.
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performed in a single tube. The ERCA amplification reac-
tion is rapid, generating signal in as little as 10 minutes,
and is incubated at a single temperature. These character-
istics make OCP ligation/ERCA easily adaptable to high
throughput automated genotyping platforms. Accurate
genotyping was obtained in screens designed to detect
four clinically relevant mutations, Factor V Leiden, Factor
II prothrombin, Hemochromatosis C282Y and Hemo-
chromatosis H63D.
Several improvements to the ligation/ERCA method [8]
have increased accuracy to levels acceptable for diagnostic
applications and reduced reaction time. Other reports
using ERCA based genotyping require PCR amplification
of the locus of interest prior to genotyping [3,16], which
is prohibitively expensive, time consuming, and more dif-
ficult to automate. We have designed ERCA primers that
are optimized for minimal misamplification and artifact
formation. With any exponential signal amplification
method, nonspecific amplification due to exponential
artifacts presents a potential problem. In ERCA as in PCR,
amplification of primer-primer artifacts can mimic spe-
cific signal if primers are not selected carefully. To avoid
this problem, commercially available primer design soft-
ware was used to design P1 and P2 primers that are
optimal for amplification. This step does not necessarily
have to be repeated for each target, however, which is an
advantage over PCR based methodologies. The primary
amplification primer sequences are present in the OCP
backbone, not in the portion of the OCP that anneals to
target, allowing optimized P1 and P2 pairs, to be used for
many different targets. In principle, a small collection of
optimized P1/P2 pairs should contain primers that can be
used for any given target.
The Q-PNA detection system [9] was used as a fluorescent
reporter during ERCA. During ERCA, Q-PNA is rapidly
displaced from the ERCA product and is physically
separated from the fluor in a bimolecular reaction, result-
ing in detectable signal in as little as 10 minutes. By com-
parison, Amplifluors typically required 60–120 minutes
to generate signal[8]. The substantial difference in time to
generate signal may be due to the nature of Amplifluor
design. In an Ampliflour, complementary DNA
sequences, fluorescent reporter, and quencher are all cov-
alently linked on the same DNA strand. The comparative
Figure 6
OCPs without hairpins, Factor V Leiden Mutation Ligation/ERCA Assay. Optimal assay conditions were as described in Meth-
ods. 1000 ng of MDA genomic DNA was incubated with probes for both alleles in the presence of ligase. ERCA mix was added 
and the reaction was followed in real time at 60°C in a Bio-Rad I-Cycler. The PCR baseline subtracted relative fluorescence 
units are shown as a function of time for both FAM (top row) and Cy3 (bottom row). Each trace (colored lines) corresponds 
to a different sample. Real time traces from reactions containing the same genotypes (either normal, heterozygous, or 
homozygous mutant) were grouped together according to genotype in each of the three columns. Genotypes were assigned as 
described in Methods.
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Figure 7
Hairpin OCPs, Factor V Leiden Mutation Ligation/ERCA Assay-. Assay was performed as described in Figure 6.
Figure 8
OCPs without hairpin, Hemochromatosis H63D Mutation Ligation/ERCA Assay-s. Assay was performed as described in Figure 
6.
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stability of the unimolecular Amplifluor hairpin is likely
to hinder displacement synthesis when compared to the
bimolecular Q-PNA system. In addition, the high local
concentration of fluor and quencher may serve to supress
signal from the Amplifluor. The Q-PNA based reporter
system consistently produces signal far more rapidly than
the Amplifluor based system, allowing time to result of
less than an hour for the entire assay.
Secondary allele specific, nonfluorescent, primers can also
be used to increase the speed and specificity of ERCA.
These primers significantly advanced the rate of ERCA
amplification, cutting the reaction time in half for the Fac-
tor V Leiden probe set (data not shown), resulting in a 20-
minute assay. Although maximum fluorescent signal
decreased slightly as each additional nonfluorescent
primer was added, the addition of one or two more prim-
ers to the reaction did not adversely influence signal
strength to the extent that genotyping was compromised.
Each of the four assays developed for this report contained
two probes, one for each allele. Using both probes in a
single reaction has been demonstrated to reduce the levels
of nonspecific amplification due to primer dimers and
misamplification of unligated probe [3]. At least one of
the probes will always be amplified, suppressing low lev-
els of nonspecific signal.
The introduction of a hairpin into the design of the open
circle probes, similar to approaches taken in molecular
beacon design [12], provides a means to regulate the
degree of ligation discrimination. A 3' and/or 5' stem-loop
structure may be designed to increase specific binding to
difficult sequences. The ratio of the hairpin stability to tar-
get annealing stability directly affects the overall target
annealing specificity. By modulating the stability of the
hairpin any OCP can be fine tuned for ligation specificity.
The OCP 3' hairpin also decreases the level of nonspecific
DNA synthesis caused by misamplification of OCP
sequences. Analysis of misamplified products has shown
that OCP sequences are usually found in the misamplified
DNA products. This means that uncircularized OCP is
able to provide a template for primer-based misamplifica-
tion. Removing the unligated OCP helps to reduce
background amplification [13], but digestion of the
unused OCP or purification of the ligated circles intro-
duces time consuming and expensive steps. Designing a 3'
hairpin into the OCP creates a self-priming sequence in
unligated OCP. During ERCA, the polymerase will extend
unligated OCP starting at the 3' end in a suicide pathway
that renders the OCP double stranded and inert. This
approach eliminates nonspecific amplification and
improves genotyping accuracy without the introduction
of separate isolation or purification steps. As demon-
strated above, removal of the hairpin sequence either by
Figure 9
Hemochromatosis H63D Mutation Ligation/ERCA Assay-Hairpin OCPs. Assay was performed as described in Figure 6.
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deletion or point mutation of the base paired region
resulted in greatly decreased genotyping accuracy for both
Factor V Leiden and Hemochromatosis H63D genotyping
assays.
Additional methods to improve ERCA specificity were
integrated into the genotyping protocol. Careful design
allowed the same P2 sequence to be used in the ERCA
reaction for both alleles. For each set of OCPs, the P2
sequence was generic. The generic P2 was not part of the
target specific portion of the probe, which allowed it to be
used in both the normal and mutant OCP. Because both
probes in each assay contained the same P2, the reaction
kinetics could be more easily balanced, promoting uni-
form amplification for both alleles. Uniform amplifica-
tion is especially important when the genotype is
heterozygous so that both alleles are accurately
represented.
Table 1: DNA sequences
Open Circle Probes Length Nucleotide Sequence
FV Normal 78 bases 5'-GCCTGTCCAGGGATCTGCTTCTTCGGTGCCCATCGCGCAGACACGATA 
GAGGAATACAACAAAATACCTGTATTCCTC-3'
FV WT-no hairpin 68 bases 5'-GCCTGTCCAGGGATCTGCTTCTTCGGTGCCCATCGCGCAGACACGATA 
ACAAAATACCTGTATTCCTC-3'
FV Mutant 78 bases 5'-GCCTGTCC AGGGATCTGCTCTGTTATCGGCCGTCGCGCAGACACGATA AAGGAATA-
CAACAAAATACCTGTATTCCTT-3'
FV Mut-no hairpin 68 bases 5'-GCCTGTCCAGGGATCTGCTCTGTTATCGGCCGTCGCGCAGACACGATA 
ACAAAATACCTGTATTCCTT-3'
FII Normal 79 bases 5'-agcctcaatgctcccagtgcACAAGACCGAAAGGGTAGTCGCGGATTGTTG 
CGCTGAGAaataaaagtgactctcagcg-3'
FII Mutant 79 bases 5'-agcctcaatgctcccagtgcACTCAATCCCAGGCGAGTCGCGGATTGTTG 
TGCTGAGAGaataaaagtgactctcagca-3'
H63 Normal 99 bases 5'-ATCATAGAACACGAACAGCTGGTAGTATTGATCGGCCACTGGTATCTCGTCCG 
TGCTAGAAGGAAACATGAGAGTAGGCTCCACACGGCGACTCTCATG-3'
H63 WT-no hairpin 99 bases 5'-ATCATAGAACACGAACAGCTGGTAGTATTGATCGGCCACTGGTATCTCGTCCG 
TGCTAGAAGGAAATCAAGAGATGGGCTCCACACGGCGACTCTCATG-3'
H63 Mutant 99 bases 5'-ATCATAGAACACGAACAGCTGGTAATGTTGACTGGTCACACGTCGTATCGTCCG 
TGCTAGAAGGAAAGATGAGAGTCAGGCTCCACACGGCGACTCTCATC-3'
H63 Mut-no hairpin 99 bases 5'-ATCATAGAACACGAACAGCTGGTAGTATTGATCGGCCACTGGTATCTCGTCCG 
TGCTAGAAGGAAATCAAGAGATGGGCTCCACACGGCGACTCTCATC
C282 Normal 89 bases 5'-CCAGGTGGAGCACCCAGGTCAGTTATCGGGCCGAGGCGCGAGTGTAAA 
CACGTATATCTCTCCCCTGGGGAAGAGCAGAGATATACGTG-3'
C282 Mutant 90 bases 5'-CCAGGTGGAGCACCCAGGTTCTACCTCAGCCCGAAGGCGCGAGTGTAAA 
CACGTATATCTCTCCCCTGGGGAAGAGCAGAGATATACGTA-3'
Primers Length Nucleotide Sequence
FV Normal P1 31 bases 5'-/56-FAM/ TCATTCGCAATCAATGGGCACCGAAGAAGCA-3'
FV Mutant P1 31 bases 5'-/5Cy3/TCATTCGCAATCAACGGCCGATAACAGAGCA-3'
FV P2 15 bases 5'-CGCGCA GACACGATA-3'
FV 5' allele specific primer 18 bases 5'-GAGGAATACAACAAAATA-3'
FV 3' allele specific primer 15 bases 5'-GATCCCTGGACAGGC-3'
FII Normal P1 28 bases 5'-/56-FAM/ TCATTCGCAATCACCCTTTCGGTCTTGT-3'
FII Mutant P1 28 bases 5'-/5Cy3/ TCATTCGCAATCACGCCTGGGATTGAGT-3'
FII P2 15 bases 5'-AGTCGCGGATTGTTG-3'
FII 5' allele specific primer 15 bases 5'-CACTGGGAGCATTGA-3'
H63 Normal P1 29 bases 5'-/56-FAM/ TCATTCGCAATCAGATACCAGTGGCCGAT-3'
H63D Mutant P1 27 bases 5'-/5Cy3/ TCATTCGCAATCAACGACGTGTGACCA-3'
H63 P2 18 bases 5'-GTCCGTGCTAGAAGGAAA-3'
H63 5' allele specific primer 17 bases 5'-TGTTCGTGTTCTATGAT-3'
H63 3' allele specific primer 15 bases 5'-GGCTCCACACGGCGA-3'
C282 Normal P1 28 bases 5'-/56-FAM/ TCATTCGCAATCACGGCCCGATAACTGA-3'
C282Y Mutant P1 28 bases 5'-/5Cy3/ TCATTCGCAATCA CGGGCTGAGGTAGAA-3'
C282 P2 15 bases 5'-AGGCGCGAGTGTAAA-3'
C282 5' allele specific primer 15 bases 5'-GGGTGCTCCACCTGG-3'
C282 3' allele specific primer 14 bases 5'-GCAGAGATATACGT-3'BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/21
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Genotyping accuracy depends on using sufficient quanti-
ties of genomic DNA target. As expected, OCP ligation/
ERCA results were influenced by the amount of genomic
DNA used in the assay. Typically, genotyping was possible
with as little as 50 ng target DNA. However, specific signal
strength increased with more DNA target, up to 1000 ng,
after which no further benefit was seen (data not shown).
WGA DNA can be produced in milligram quantities from
nanograms [10] of original sample allowing use of high
DNA concentration for optimal signal. As a result, 1000
ng WGA DNA was used to obtain optimal genotyping
reaction conditions. The results obtained for the WGA
DNA agreed in every instance with the known genotypes
determined by RFLP. WGA product should also be com-
patible with other genotyping assays where better results
can be obtained using more target DNA.
Many aspects of probe design are open to manipulation,
and in practice probes can be successfully designed for
most target sequences of interest. Pickering et al. demon-
strated a 95% success rate in designing OCPs for 99
different targets on the first attempt [3]. Probes can be
designed against either strand of genomic DNA, and the
backbone portion can also be varied. Optimization of Tm
parameters, and sequence allows rapid design of OCPs
with a high degree of success.
The degree to which a genotyping assay needs to be opti-
mized depends in part on the purpose of the assay. A gen-
otyping system intended for diagnostic purposes needs to
meet the highest standards of accuracy, robustness, and
throughput, as compared to a system that is intended
solely for research purposes. In recognition of the expecta-
tion that 100% accuracy is a requirement, even under sub-
optimal conditions, the assays developed for the targets in
this report have undergone extensive optimization to
maximize accuracy even under less than optimal condi-
tions. As a result, the concentrations of primers, probes
and polymerase vary between assays. After determining
the best conditions for each individual genotyping assay,
the expectation is that these conditions would be the best
possible for genotyping large numbers of samples with
high accuracy. The critical nature of the information
derived from the output of the assay justifies the extra
optimization effort. To minimize the potential for error,
the accuracy for a single assay was compared to the
accuray for the same assay performed in triplicate.
Depending on the assay requirements, the level of accu-
racy can be selected by increasing or decreasing the
number of repeats. The demonstration that high levels of
input genomic DNA improve robustness of genotyping
results is paralleled by PCR results. WGA can be used to
generate sufficient DNA for genotyping using large quan-
tities of template. The cost of performing WGA is offset by
the fact that sample prep is unnecessary; WGA product can
be performed directly on crude blood sample and yields
enough DNA for dozens or hundreds of genotyping reac-
tions[11]. Under different circumstances, it may be neces-
sary to rapidly generate assays for a large number of SNPs.
For this, the emphasis could be placed on optimization of
assay design. Amounts of input DNA, primers and
polymerase could be standardized, rapidly yielding accu-
rate genotyping assays but without the highest accuracy
under suboptimal conditions. The process of OCP liga-
tion followed by ERCA has been designed such that
genomic DNA can be genotyped directly in less than an
hour. Hundreds of individual samples were genotyped
with over 99% accuracy. Accurate genotyping was demon-
strated for both genomic DNA and whole genome ampli-
fied DNA. Isothermal exponential amplification produces
a fluorescent signal from ligated OCP using nanomolar
amounts of probe. Because OCP ligation/ ERCA does not
rely on thermal cycling for amplification, amplification
kinetics are not limited by cycling rate. The exponential
nature of the reaction produces millions of fold amplifica-
tion in as little as 20 minutes. Output can be read on a flu-
orescent plate reader, real time PCR instrument,
fluorescent imager, or other device equipped with the
ability to measure fluorescent signals. OCP ligation/
ERCA probes can be multiplexed. OCP ligation and ERCA
reactions for each SNP target are performed in a single
Table 2: Table of patient sample numbers and genotyping accuracy.
Assay Number of Individual Samples 
Mutant:Hetero:Normal
Single Assay Accuracy Observed Assay Accuracy in 
Triplicate
Factor V Leiden 13:98:105 99.5% 100%
Hemochromatosis C282Y 13:93:84 99.5% 100%
Hemochromatosis H63D 1:48:89 99.5% 100%
Factor II Prothrombin 2:12:284 99.4% 100%
For each of the assays (column 1) the number of different samples screened are grouped according to genotype (column 2). Mutant (homozygous 
mutant), heterozygous, normal (homozygous normal). The accuracy obtained for each single genotyping assay is shown in column three. The 
observed genotyping accuracy for the samples as tested in triplicate is shown in column four.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/21
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tube, and are easily scalable from 96 to 384 well formats,
making OCP ligation/ ERCA ideal for high throughput
screening.
Methods
Hairpin OCP Design
All oligomers were ordered from Integrated DNA Technol-
ogies, Inc.(Coralville, IA). Sequences of oligomers are
shown in Table 1. All OCPs were 5' phosphorylated and
gel purified. OCPs were designed such that the 3' terminal
nucleotide annealed opposite the mutation of interest
(Figure 1). The Tm for the 3' arm of the probe annealed to
target was designed to be between 60–65°C. The 5' arm of
all OCPs annealed to target upstream of the mutation and
was designed to have a Tm of approximately 70°C. Oligo
Figure 10
Factor V Leiden Mutation: 87 different patient samples, 3 different genotypes. Ligation/ERCA genotyping results visualized as 
both a real-time assay and as an end-point. Assay conditions were as described in Methods for specific genotyping assay targets. 
1000 ng of WGA genomic DNA was incubated with OCPs for both alleles in the presence of ligase. ERCA reactions were 
monitored in real time in the Bio-Rad I-cycler. Each colored trace in the real time charts corresponds to a different sample. At 
the end of the assay, approximately one-hour after addition of DNA polymerase, the intensity of both FAM and Cy3 fluores-
cence were measured for each sample in a fluorescent plate reader. End-point genotyping results were analyzed by the fuzzy 
cluster program and grouped automatically into genotypes as described in Methods.
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6 (Molecular Biology Insights, Inc., Cascade, CO) was
used to calculate Tm values.
To reduce or eliminate the artifactual amplification of
unligated OCPs, a hairpin was designed into the 3' end of
the OCP, with approximately 10 bases in the stem and 10
in the loop. The hairpin was calculated to be stable at
60°C in the context of the entire OCP using the DNA fold-
ing server at Michael Zucker's website http://bio-
info.math.rpi.edu/~zukerm/ OCP sequence was chosen
such that the hairpin was the only stable structure in the
OCP, with a ∆G of -0.5 to -1.5 kcal/mol.
Generic P1 and P2 design
ERCA primers P1 and P2 were chosen using Oligo 6.
These were generic primer sequences, and could be used
to amplify any circle sequence. First, 10–20 kb of
randomly generated DNA sequence was scanned for prim-
ers using settings limiting 3' dimer ∆G to -1.0 kcal/mol, 3'
dimer length to 3, 3' terminal stability range -5.5 to -8.0
kcal/mol, GC clamp stability to -10 kcal/mol, no accepta-
ble loop, Tm range 52.1 to 56.2°C. Compatible primers
were selected using the multiplex function of Oligo 6. A
subset of these compatible primers was utilized as generic
P1 and P2 primers (see Table 1). ERCA P1 primers were
Figure 11
Factor II Prothrombin Mutation: 32 repeats of 3 patient samples, 3 different genotypes. Assay was performed as described in 
Figure 10.
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labeled with FAM (if paired with the normal OCP) or 5-
Cy3 (if paired with the mutant OCP) and were RP-HPLC
purified. P2 primers were purified by desalting.
Allele Specific ERCA primers
The sequence of these primers was chosen from the target
specific 5' and 3'-arms of the OCP, either complementary
to the OCP (5'-arm) or the exact sequence of the OCP (3'-
arm). These primers annealed to both the normal and
mutant OCPs. The sequences of these allele specific
primers are shown in Table 1. Allele specific primers were
desalted after synthesis.
Q-PNA
Exponential amplification of circularized OCP (see Figure
2) was accomplished using generic primers P1 and P2,
along with allele specific primer(s). Each P1 primer con-
tained a universal 13 base 5'-tail (see Table 1) with a fluo-
rescent dye at the 5'-end. Fluorescence was quenched in
unincorporated primers by the annealing of a 13-residue
PNA molecule, Q-PNA-13 (Applied Biosystems/Boston
Probes, Bedford, MA). The sequence of Q-PNA-13 is Ac-X-
OO-TGA-TTG-CGA-ATG-A-Lys (Dabcyl). The C-terminal
dabcyl was positioned so that it was proximal to the 5'-flu-
orescent moiety on the DNA reporter, quenching fluores-
Figure 12
Hemochromatosis H63D Mutation: 71 different patient samples, 3 different genotypes. Assay was performed as described in 
Figure 10.
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cence when the reporter and Q-PNA-13 were annealed, as
shown in Figure 2. After P1 primer is incorporated into
ERCA product, Q-PNA is displaced, producing a fluores-
cent signal.
Genomic DNA
Genomic DNA samples were purchased from Coriell Cell
Repositories, Camden, NJ. Human Variation Panel, Cau-
casian panel of 100, Reference # HD100CAU, was used as
non-mutant controls and for general screening purposes.
Human samples containing specific mutations were also
purchased from Coriell: Factor V Leiden mutation (heter-
ozygous NA14642 and homozygous NA14899); Hemo-
chromatosis C282Y (heterozygous NA14642,
homozygous NA14620); and Hemochromatosis H63D
(heterozygous NA14641 and homozygous NA13591);
Factor II Prothrombin mutation (heterozygous NA16028
and homozygous NA16000). Other patient DNA samples
were genotyped using RFLP, and an aliquot of the purified
DNA was subsequently used either directly in genotyping
reactions, or used after Whole Genome Amplification
(WGA).
Figure 13
Hemochromatosis C282Y Mutation: 96 different patient samples, 3 different genotypes. Assay was performed as described in 
Figure 10.
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Whole Genome Amplification (WGA) of genomic DNA 
samples
For some rare genotypes, it was only possible to obtain a
few nanograms of sample, insufficient for more than one
genotyping reaction. As a result, the rare samples were
subjected to whole genome amplification (WGA), which
yielded enough DNA for 200 or more reactions. WGA was
performed as described previously [10]. Briefly, 10 ng of
each individual genomic sample was amplified into 40 µg
of product by adding 99 µl of amplification mix and incu-
bating at 30°C for 6 hours. Quality control assays demon-
strating that whole genome amplification was successful
were performed for locus 979 and 1004 as described [10],
and amplified DNA was used directly in genotyping
reactions at the same concentration as the original
genomic DNA, typically 200 ng/reaction.
Genotyping reactions
50 ng to 1 µg of either genomic DNA or WGA genomic
sample was mixed with OCP (typically 0.5 nM final con-
centration) and 0.5 unit of Ampligase (Epicentre Technol-
ogies, Madison, WI) in 1x Ampligase buffer (Epicentre),
for a total volume of 10 µl. The reaction was heated to
95°C for 10 seconds, and cooled to 63–68°C for 5–20
minutes, during which time OCP annealed to genomic
target and was circularized by ligase. The reaction was sub-
sequently heated to 95°C for 10 minutes to release ligated
circles from genomic DNA. The reaction was cooled to
4°C, and 20 µl ERCA reaction mix was added (typically 16
units BST polymerase (New England Biolabs, Beverly,
MA), 6 mM dNTPs, 0.5 µM P1, 0.5 µM P2, 4 µM Q-PNA,
7.5 µM TMAO in 1x ThermoPol Buffer II, all concentra-
tions final). Reactions were incubated at 60°C for 1 hour
in an I-Cycler (BioRad, Hercules, CA) reading both FAM
and Cy3 channels. Signals typically appeared after 10–20
minutes.
Specific reaction component concentrations
FV ligation reaction conditions
0.5 nM wt OCP and 0.5 nM mut OCP (final concentra-
tion); 0.5 U ampligase.
FV ERCA reaction conditions
0.5 µM WT P1; 0.5 µM mutant P1; 0.75 µM P2; 0.75 µM
5'-allele specific primer; 0.75 µM 3'-allele specific primer;
4  µM PNA (final concentrations); 24–32 U DNA
polymerase.
FII ligation reaction conditions
0.5 nM wt OCP and 0.5 nM mut OCP (final concentra-
tion); 0.5 U ampligase.
FII ERCA reaction conditions
0.5 µM WT P1; 0.7 µM mutant P1; 0.9 µM P2; 0.4 µM 3'-
allele specific primer; 4 µM PNA (final concentrations);
16 U DNA polymerase.
Hemochromatosis H63 ligation reaction conditions
0.1 nM wt OCP and 1.2 nM mut OCP (final concentra-
tion); 0.5 U ampligase.
Hemochromatosis H63 ERCA reaction conditions
0.4 µM WT P1; 0.5 µM mutant P1; 0.75 µM P2; 0.5 µM 5'-
allele specific primer; 0.5 µM 3'-allele specific primer; 4
µM PNA (final concentrations); 16 U DNA polymerase.
Hemochromatosis C282 ligation reaction conditions
0.1 nM wt OCP and 1.2 nM mut OCP (final concentra-
tion); 0.5 U ampligase.
Hemochromatosis C282 ERCA reaction conditions
0.4 µM WT P1; 0.5 µM mutant P1; 0.75 µM P2; 0.5 µM 5'-
allele specific primer; 0.5 µM 3'-allele specific primer; 4
µM PNA (final concentrations); 16 U DNA polymerase.
Determination of genotype
In this retrospective study, the genotype of each sample
was known. Genotyping by RFLP analysis (data not
shown) was performed prior to OCP ligation/ ERCA
genotyping, and the results of OCP ligation/ ERCA analy-
sis were compared to the RFLP analysis results.
Real Time OCP ligation/ ERCA
The genotype for each sample was determined by ampli-
tude of amplification. The average amplification thresh-
old time for all amplified reactions was determined using
the I-Cycler software. Fluorescence traces were normalized
using early cycles as a baseline, and a threshold value was
determined, typically at 10-fold above the average stand-
ard deviation of the baseline values. Threshold cycle for
each trace was measured at the point where the trace
crossed the threshold value. Threshold cycle values fell
into three distinct clusters, one each for homozygous
normal, heterozygous, and homozygous mutant. Reac-
tions with times more than 2 standard deviations beyond
the mean cluster value were considered failures and
repeated. In general, amplification reactions with an
increase of less than 300 units were scored as negative.
Any reaction with amplification of 300 fluorescence units
above baseline or greater was scored as positive. Reactions
with fluorescent units between 101–299 above baseline
were repeated. Any reaction where signal was baseline for
both alleles was repeated.
End Point OCP ligation/ ERCA
ERCA reactions were allowed to incubate at 60°C until
the reaction was expected to be complete (30 to 40Publish with BioMed Central    and   every 
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minutes, depending on the assay). After the reaction was
complete, the results could be read at any time. Some reac-
tions were allowed to remain at room temperature over-
night, some were stored at 4°C, some were frozen at -
20°C. In each case, the reaction was protected from light
to prevent photobleaching of the fluorescent reporters.
The genotype of each sample was determined automati-
cally using a modified fuzzy c-means clustering algorithm
[3], which groups the data into three genotypes plus a neg-
ative control, and assigns a confidence level to each geno-
typing call from 0 (not in cluster) to 1 (100% certainty
that point belongs to cluster).
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